Drug-drug interactions with direct oral anticoagulants in Belgian primary care patients with non-valvular atrial fibrillation
(2026) Scientific Reports — Vol. 16, n° 1, p. 23253 (2026)
Files
260521 Fuchs VA, Sci Rep, 2026.pdf
Open Access - Adobe PDF
- 900.85 KB
Details
- Authors
- Abstract
- Direct oral anticoagulants (DOACs) are widely prescribed in primary care, but co-prescription with interacting drugs may increase thromboembolic and major bleeding risks. We conducted a retrospective cohort study in Belgium in 2022-2023 using the real-world THIN database to evaluate the prevalence of DOAC-related drug-drug interactions (DDIs) in general practitioners’ (GPs) prescriptions for patients with non-valvular atrial fibrillation (NVAF) and to assess factors associated with pharmacodynamic DDIs. DDIs were defined as the co-prescription of a DOAC and an interacting drug within the same week. Factors associated with pharmacodynamic DDIs were assessed using multivariable logistic regression. Among 5,637 patients receiving 13,334 DOAC prescriptions, 22.9% had at least one DDI during the year. Overall, 17.8% of GP-issued DOAC prescriptions involved a DDI, of which 91.5% were pharmacodynamic. The most frequently interacting drug classes were selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors (44.2%), antiplatelets (22.6%) and non-steroidal anti- inflammatory drugs (19.6%). Higher CHA2DS2-VASc score and receiving multiple DOAC types were associated with higher odds of pharmacodynamic DDIs, whereas edoxaban use and older age were associated with lower odds. Most DOAC-related interactions in primary care involved bleeding-risk drugs highlighting the need to prioritizing identification and review of these high-risk associations to support safer anticoagulation prescribing.
- Affiliations
Citations
Fuchs, V., Zerah, L., Spinewine, A., & Henrard, S. (2026). Drug-drug interactions with direct oral anticoagulants in Belgian primary care patients with non-valvular atrial fibrillation. Scientific Reports, 16(1), 23253. https://doi.org/10.1038/s41598-026-53817-5 (Original work published 2026)